AAAAAA

   
Results: 1-18 |
Results: 18
The effect of prolactin and bromocriptine on human peripheral immune status
Authors: Kadioglu, P Acbay, O Demir, G Gazioglu, N Gundogdu, S
Citation: P. Kadioglu et al., The effect of prolactin and bromocriptine on human peripheral immune status, J ENDOC INV, 24(3), 2001, pp. 147-151
Serum erythropoietin level in anemic cancer patients
Authors: Ozguroglu, M Arun, B Demir, G Demirelli, F Mandell, NM Buyukunal, E Serdengecti, S Berkarda, B
Citation: M. Ozguroglu et al., Serum erythropoietin level in anemic cancer patients, MED ONCOL, 17(1), 2000, pp. 29-34
Detection of t(14;18) in Turkish follicular lymphomas using the polymerasechain reaction
Authors: Sayhan, N Tuzuner, N Aki, H Demir, G Berkarda, B
Citation: N. Sayhan et al., Detection of t(14;18) in Turkish follicular lymphomas using the polymerasechain reaction, LEUK RES, 24(6), 2000, pp. 475-479
A case of metastatic malignant melanoma presenting with hematuria
Authors: Demirkesen, O Yaycioglu, O Uygun, N Demir, G Yalcin, V
Citation: O. Demirkesen et al., A case of metastatic malignant melanoma presenting with hematuria, UROL INTERN, 64(2), 2000, pp. 118-120
Serum cardiolipin antibodies in cancer patients with thromboembolic events
Authors: Ozduroglu, M Arun, B Erzin, Y Demir, G Demirelli, F Mandel, NM Buyukunal, E Serdengecti, S Berkarda, B
Citation: M. Ozduroglu et al., Serum cardiolipin antibodies in cancer patients with thromboembolic events, CL APPL T-H, 5(3), 1999, pp. 181-184
Effect of hematocrit on blood pressure via hyperviscosity
Authors: Cinar, Y Demir, G Pac, M Cinar, AB
Citation: Y. Cinar et al., Effect of hematocrit on blood pressure via hyperviscosity, AM J HYPERT, 12(7), 1999, pp. 739-743
Unusual manifestations of B-cell disorders - Case 1: Multiple myeloma withpredominant phalangeal involvement
Authors: Ozguroglu, M Aki, H Demir, G Demirelli, F Mandel, NM
Citation: M. Ozguroglu et al., Unusual manifestations of B-cell disorders - Case 1: Multiple myeloma withpredominant phalangeal involvement, J CL ONCOL, 17(3), 1999, pp. 1083-1084
Usefulness of the epithelial tumor marker CA-125 in non-Hodgkin's lymphoma
Authors: Ozguroglu, M Turna, H Demir, G Doventas, A Demirelli, F Mandel, NM Buyukunal, E Serdengecti, S Berkarda, B
Citation: M. Ozguroglu et al., Usefulness of the epithelial tumor marker CA-125 in non-Hodgkin's lymphoma, AM J CL ONC, 22(6), 1999, pp. 615-618
Paraneoplastic hyperpigmentation secondary to lung cancer resolving after chemotherapy
Authors: Ozguroglu, M Tahan, V Ozguroglu, E Ozaras, R Demir, G
Citation: M. Ozguroglu et al., Paraneoplastic hyperpigmentation secondary to lung cancer resolving after chemotherapy, AM J CL ONC, 22(5), 1999, pp. 533-534
Bilateral inflammatory breast metastases of epithelial ovarian cancer
Authors: Ozguroglu, M Ersavasti, G Ilvan, S Hatemi, G Demir, G Demirelli, FH
Citation: M. Ozguroglu et al., Bilateral inflammatory breast metastases of epithelial ovarian cancer, AM J CL ONC, 22(4), 1999, pp. 408-410
Anaphylaxis from intraperitoneal infusion of cisplatin - A case report
Authors: Ozguroglu, M Demir, G Demirelli, F Mandel, NM
Citation: M. Ozguroglu et al., Anaphylaxis from intraperitoneal infusion of cisplatin - A case report, AM J CL ONC, 22(2), 1999, pp. 172-173
"Multi-enzyme-targeted" immunochemotherapy: A salvage therapy protocol
Authors: Klein, HO Demir, G
Citation: Ho. Klein et G. Demir, "Multi-enzyme-targeted" immunochemotherapy: A salvage therapy protocol, ANTICANC R, 19(4C), 1999, pp. 3451-3458
Immunomodulating therapy with rIL-2 and interferon alpha induces in vivo expression of Bcl-2, Fas (APO-1/CD95), and Fas ligand on peripheral lymphocytes (A pilot study)
Authors: Demir, G Ozguroglu, M Sayhan, N Molinas-Mandel, N Demirelli, F Buyukunal, E Tuzuner, N Serdengecti, S Berkarda, B
Citation: G. Demir et al., Immunomodulating therapy with rIL-2 and interferon alpha induces in vivo expression of Bcl-2, Fas (APO-1/CD95), and Fas ligand on peripheral lymphocytes (A pilot study), ANTICANC R, 19(4C), 1999, pp. 3517-3520
Anorectal melanoma metastatic to the breast
Authors: Ozguroglu, M Ozaras, R Tahan, V Demirkesen, C Demir, G Dogusoy, G Buyukunal, E Serdengecti, S Berkarda, B
Citation: M. Ozguroglu et al., Anorectal melanoma metastatic to the breast, J CLIN GAST, 29(2), 1999, pp. 197-199
Primary splenic tuberculosis in a patient with nasal angiocentric lymphoma- Mimicking metastatic tumor on abdominal CT
Authors: Ozguroglu, M Celik, AF Demir, G Aki, H Demirelli, F Mandel, N Buyukunal, E Serdengecti, S Berkarda, B
Citation: M. Ozguroglu et al., Primary splenic tuberculosis in a patient with nasal angiocentric lymphoma- Mimicking metastatic tumor on abdominal CT, J CLIN GAST, 29(1), 1999, pp. 96-98
Expression of p53 protein and resistance to preoperative chemotherapy in locally advanced gastric carcinoma
Authors: Ozguroglu, M Demir, G
Citation: M. Ozguroglu et G. Demir, Expression of p53 protein and resistance to preoperative chemotherapy in locally advanced gastric carcinoma, CANCER, 86(3), 1999, pp. 547-549
Degradation of some chlorinated organic materials by white rot fungus (Phanerochaete chrysosporium) in waters
Authors: Demir, G Barlas, H Bayat, C
Citation: G. Demir et al., Degradation of some chlorinated organic materials by white rot fungus (Phanerochaete chrysosporium) in waters, FR ENV BULL, 7(12A), 1998, pp. 927-933
Immune effects of low-dose subcutaneous interleukin-2 in patients with metastatic malignant melanoma
Authors: Demir, G Demirelli, F Ozguroglu, M Molinas-Mandel, N Buyukunal, E Tuzuner, N Serdengecti, S Berkarda, B
Citation: G. Demir et al., Immune effects of low-dose subcutaneous interleukin-2 in patients with metastatic malignant melanoma, INT J IMM T, 14(3), 1998, pp. 163-168
Risultati: 1-18 |